Analyst Actions -- 11/14/2011

 | Nov 14, 2011 | 8:27 AM EST  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

tol

,

qcom

,

cat

,

bsx

,

tsn

,

vlo

,

pfe

,

amgn

,

dhi

,

amzn

,

msft

,

rimm

,

crm

,

tjx

,

a

,

AMAT

,

hsy

,

gmcr

Alexion Pharmaceuticals target boosted at Oppenheimer

Shares of ALXN now seen reaching $75, according to Oppenheimer. Expect approval in STEC-HUS. Outperform rating.

 -----

Amazon.com estimates, target raised at JP Morgan

Shares of AMZN now seen reaching $250, according to JP Morgan. Estimates also increased, as Kindle Fire should drive growth over the coming quarters.

-----

Amgen downgraded at Leerink

AMGN was downgraded from Outperform to Market Perform, Leerink Swann said. Company lacks potential catalysts for 2012.

-----

Amylin Pharmaceuticals upgraded at Baird

AMLN was upgraded from Neutral to Outperform, Robert Baird said. $15 price target. Eli Lilly overhang has removed and Bydureon should receive FDA approval.

-----

Applied Materials estimates, target increased at UBS

Shares of AMAT now seen reaching $13, according to UBS.  Estimates also increased on strength at foundry.  Neutral rating.

-----

Agilent  numbers lowered at Jefferies

Shares of A now seen reaching $60, according to Jefferies. Estimates also lowered, on lower cash forecasts. Buy rating.

-----

Boston Scientific estimates cut at Morgan Stanley

BSX estimates were reduced through 2013, Morgan Stanley said. Consensus expectations appear too high. Equal-weight rating.

-----

Caterpillar placed on Conviction Buy List at Goldman

CAT was added to the Conviction Buy list, Goldman Sachs said. $118 price target.  Incremental margin growth should accelerate in the coming quarters.

-----

CTrip.com downgraded at Brean

CTRP was downgraded from Buy to Hold, Brean Murray said. Offline growth is hurting margins.

----- 

Cullen/Frost Bankers, Inc estimates raised at Jefferies

CFR estimates were raised through 2012, Jefferies said. Following recently reported earnings. Hold rating.

-----

Dollar Tree numbers raised at Jefferies

Shares of DLTR now seen reaching $88, according to Jefferies. Estimates also raised, on EBIT margin expansion and its defensive profile. Buy rating.

-----

DR Horton downgraded at Guggenheim

DHI was downgraded from Buy to Neutral, Guggenheim said. $13 price target. Gross margin may remain weak for several quarters.

-----

DSW Inc. downgraded at Citigroup

DSW was downgraded from Buy to Neutral, Citigroup said.  $52 price target.  Expect slower growth over the next four quarters. 

-----

Eaton Vance downgraded at Citigroup

EV was downgraded from Neutral to Sell, Citigroup said.  $22 price target.  Clearly losing retail market share.

-----

Green Mountain Coffee downgraded at Argus

GMCR was downgraded from Buy to Hold, Argus Research said. Company appears to have lost its growth momentum.

----- 

Hershey Foods downgraded at Argus

HSY was downgraded from Buy to Hold, Argus Research said. Company may struggle to maintain recent growth momentum.

-----

Medical Properties Trust target raised at Jefferies

Shares of MPW now seen reaching $10.50, according to Jefferies. Growth aspect of MPW story continues to be attractive. Hold rating.

-----

Microsoft estimates reduced at Ticonderoga

MSFT estimates were cut through 2013, Ticonderoga Securities said. Company is facing higher costs.

-----

Pfizer downgraded at Leerink

PFE was downgraded from Outperform to Market Perform, Leerink Swann said. Company lacks near-term catalysts.

-----

Qualcomm target raised at Morgan Stanley       

Shares of QCOM now seen reaching $65, according to Morgan Stanley. Management will likely have an upbeat tone at the analyst meeting this week. Overweight rating.

-----

Questcor Pharmaceuticals numbers raised at Jefferies

Shares of QCOR now seen reaching $50, according to Jefferies. Estimates also raised, on sustained sales growth in NS. Buy rating.

-----

Research in Motion estimates lowered at UBS

RIMM estimates lowered through 2013, UBS said.  Earnings power remains elusive.  Maintain $26 price target and Neutral rating.

-----

salesforce.com (CRM) upgraded at Citigroup

CRM was upgraded from Neutral to Buy, Citigroup said.  $158 price target.  Increasing confidence in long term profitability potential.

-----

Spirit AeroSystems added to US 1 List at Bofa Merrill

SPR was added to the US 1 List, Bank of America Merrill Lynch said.  Expect company to generate positive FCF for the first time since 2005.  $26 price target and Buy rating. 

-----

Teekay estimates lowered at Credit Suisse

TK estimates were cut through 2012, Credit Suisse said. Company is buying back less stock. Outperform rating and $35 price target.

-----

TJX estimates raised at UBS

TJX estimates increased through 2013, UBS said.  SYMS bankruptcy an incremental opportunity for Northeast store growth. 

-----

Toll Brothers numbers increased at Goldman

TOL estimates were raised through 2013, Goldman Sachs said. Company recently boosted guidance. Buy rating and new $20 price target.

-----

TW Telecom upgraded at Morgan Stanley

TWTC was upgraded from Equal-weight to Overweight, Morgan Stanley said. Company is seeing solid sales growth, despite the macro environment. $22 price target.

-----

Tyson Foods upgraded at JP Morgan

TSN was upgraded from Neutral to Overweight, JP Morgan said. Stock has 40% upside potential from current levels.

 -----

Valero estimates upped at Oppenheimer

VLO estimates were boosted through 2012, Oppenheimer said. Company will likely buy back more shares with free cash flow. Outperform rating.

-----

Veeco Instruments estimates lowered at Citigroup

VECO estimates lowered through 2012, Citigroup said.  Expiring subsidies, significant oversupply, weak demand, and elevated inventory.  Maintain $27 price target and Neutral rating.

-----

WMS Industries numbers reduced at Goldman

Shares of WMS now seen reaching $21, according to Morgan Stanley. Estimates also cut, as the company is seeing slower growth across the board.

Columnist Conversations

Right now ICE is still considered to be within a larger downtrend unless the zones discussed in the article (t...
big X up 8%+ after hours. 30 last. nice short squeeze.
Market woke up a bit today to the fact that the tensions emanating out of Ukraine are not going anywhere as th...
In my article this morning, I speculated this could be the bottom for Twitter. I thought investors would shif...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.